Manufacturer of microinfusion pumps used to distribute insulin for the treatment of diabetes. Products are sold to people living with diabetes through direct operations and distributors. The bulk of revenue is derived from activity in the medical industry. This company was capitalized by private investment and venture capital. International sales are between 10% and 25% of sales. Products include microinfusion pumps, glucose monitoring systems.